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Background: During the 2013 outbreak, 4638 infection cases and 32 deaths have been recorded in the southern
part of Laos. In recent years, the chikungunya virus (CHIKV) emerged in the part of the country bordering
Cambodia. Dengue virus (DENV) and CHIKV are transmitted by common mosquito vectors. Both diseases have
similar clinical presentations; therefore, CHIKV infections might go undiagnosed in DENV-endemic areas. Thus, rapid
detection and accurate diagnosis are crucial for differentiating between the two viruses (DENV and CHIKV). In this
study, we demonstrated that CHIKV and two serotypes of DENV are circulating in Laos. In addition, we encountered
patients that had been concurrently infected with multiple DENV serotypes or DENV and CHIKV.
Methods: Plasma samples were collected from 40 patients with suspected DENV infections during an outbreak
between July and August 2013. The reverse transcription polymerase chain reaction was performed to detect the
four DENV serotypes and CHIKV using specific primers. Specifically, the complete envelope gene sequences of the
viruses were sequenced and subjected to phylogenetic analysis.
Results: Forty acute-phase plasma samples from patients with suspected dengue infections were tested for the
presence of DENV viral RNA using molecular methods. Among the 40 samples, 14 samples were positive for DENV,
2 samples were positive for both viruses (DENV-2 and DENV-3), whereas DENV-1 and DENV-4 were not detected
during the study period. We also encountered 10 samples that were positive for CHIKV. Of the 10 CHIKV-positive
samples, 3 samples were co-infected by DENV-2, and 2 samples were co-infected by DENV-3. Phylogenetic analysis
revealed that the 2013 dengue outbreak in Laos involved DENV-2 genotype Asian I and DENV-3 genotype II.
Moreover, the Laotian CHIKV strains grouped together with those isolated during outbreaks on the Indian Ocean
Islands within the East Central South African genotype.
Conclusions: These findings revealed that two serotypes (DENV-2 and DENV-3) and CHIKV were detected.
Furthermore, infection of multiple DENV serotypes and CHIKV was also observed in the 2013 dengue outbreak. This
is the first documented evidence of co-infection with CHIKV and one of two DENV serotypes.
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DF (dengue fever) is a mosquito-borne viral disease
caused by the dengue virus (DENV), which belongs to
the Flavivirus genus, Flaviviridae family, and has been
categorized into four different serotypes (DENV-1 to
DENV-4). It commonly occurs in tropical and subtrop-
ical regions [1]. The World Health Organization (WHO
2009) estimates that more than 50 million dengue infec-
tions occur yearly, resulting in half a million cases of
dengue hemorrhagic fever (DHF) and 22,000 deaths,
mainly among children. DENV is endemic in Southeast
Asia, the Pacific, and the Americas [2]. However, in re-
cent years, the hyperendemic circulation of all four den-
gue serotypes has been detected in Southeast Asian
countries [3]. Other Flavivirus such as Japanese enceph-
alitis (JE) is also endemic, occurring in Laos [4].
In Laos, dengue infections exhibit a cyclical pattern, i.e.,
they occur approximately every 2–5 years [5]. DENV sero-
types responsible for such infections in Laos were first
confirmed in 1994, and a case involving co-infection with
two DENV serotypes was reported [6]. Since then, larger
epidemics caused by all four serotypes have occurred [7,
8]. DENV-1 has emerged in several provinces and caused
sporadic clinical cases in different areas of Laos between
2010 and 2011 [8]. The dominant circulating serotype
subsequently switched from DENV-1 to DENV-3, and
DENV-3 virus was the predominant DENV circulating in
Laos at the end of June 2012 [7]. However, while some
suspected cases of DENV infection were confirmed using
laboratory detection, other cases of dengue infection were
diagnosed based on clinical symptoms [9].
Chikungunya has been identified in more than 60 coun-
tries in Asia, Africa, Europe, the Americas, the Indian
Ocean, and Pacific Islands [10]. In 2012, in a community
survey, 31 % (16 of 52) cases of chikungunya virus
(CHIKV) infection was recorded in the southern part of
Laos [11]. The CHIKV is a member of the Alphavirus
genus, which belongs to the Togaviridae family. Infection
of CHIKV has similar clinical presentations with DENV
and co-circulates in overlapping geographic regions;
hence, it can be underdiagnosed in areas where the
DENV-endemic occurs [10]. Few studies of the molecular
epidemiology of serotypes/or genotypes of DENV and
CHIKV were reported in Laos [7, 8, 11].
In the present study, the specimens were screened for
the presence of DENV and CHIKV using the reverse
transcription polymerase chain reaction (RT-PCR) dur-
ing the 2013 outbreak of DF in southern Laos. Our
results highlight that CHIKV and two serotypes of
DENV are circulating in the southern part of Laos,
which shares borders with Cambodia and Thailand. In
addition, we encountered patients that had been concur-
rently co-infected with multiple DENV serotypes or
DENV and CHIKV.Methods
Study sites
Champasak province (CPS) (610 km south of Vientiane
capital) lies to the southwest in Laos (Fig. 1). It shares a
border with Thailand to the west, Salavan, Sekong, and
Attapeu provinces to the north and east, and Cambodia
to the south. The Champasak hospital, a provincial hos-
pital, is arranged in the third level of health services at
the national level where there is inadequate laboratory
facilities to diagnosis of infectious diseases.
Clinical characterization of patients and sample collection
Forty hospitalized patients and 3 additional cases (1 case
from Oudomsay province and 2 cases from Vientiane
capital) were investigated during the outbreak of DF/
DHF from the end of July to the beginning of August
2013. Forty patients, aged 5 to 65 years presented with
acute DENV infection at days 1–6 after the onset of
fever with two more of the following symptoms: head-
ache, myalgia, arthralgia, skin rash, and hemorrhage. All
of these 40 patients were diagnosed with DENV infec-
tion. The history of their illness and complete blood
counts: white blood cells (WBC), platelet counts (PLT),
and hematocrit (HCT), were obtained from a physician
at the Champasak hospital.
A total of 8–10 ml of whole blood samples are col-
lected in tubes that contained EDTA as an anticoagulant.
Plasma samples were separated and preserved in an
RNA Shield™ reagent (Zymo Research) that could pro-
tect from RNA degradation. These specimens were then
transferred to the Laboratory of Public Health depart-
ment, Kansai Medical University, Japan.
Laboratory procedures
The plasma samples were separated from the patients’
whole blood by centrifugation at 1000×g for 5 min at 4 °
C. A total of 200–500 μl of plasma samples were directly
used for the viral RNA extraction and RT-PCR. The
remaining plasma specimens were kept at −20 °C prior
to testing and were stored at −80 °C until further use.
RNA extraction and PCR
Total RNA was extracted from patient’s plasma sample
using TRIzol® reagent (Invitrogen Inc.), according to the
manufacturer’s protocol with the following modifica-
tions. Then, the extracted RNA was used to synthesize
first-strand cDNA with random primers and reverse
transcriptase (ReverTra Ace®: Toyobo) for 1 h at 42 °C
[12]. In the PCR analysis, the cDNA was used as a tem-
plate and amplified using serotype-specific primers for
serotypes D1 to D4 of DENV according to the method
of Lanciotti et al. [13] or a specific primer for CHIKV
[14]. The general PCR conditions were as follows: 94 °C
for 2 min, 98 °C for 10 s, and 54–62 °C for 30 s for 35–
Fig. 1 A map of the study area (Champasak Province, Lao PDR)
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were electrophoresed and visualized by staining 1.5 %
agarose gel with ethidium bromide, and specific bands
were visualized with an ultraviolet transilluminator.
Sequencing of the envelope (E) gene and E1 gene
In order to identify the genotypes of DENV and CHIKV,
we tried to analyze the sequences of the DENV-2, DENV-
3, and CHIKV isolates detected during the screening
process described above. PCR was performed by using
cDNA derived from the DENV-2-, DENV-3-, or CHIKV-
positive patients’ samples as a template and a primer pair
for each target region to amplify the complete envelope
(E) gene of DENV and E1 envelope glycoprotein gene of
CHIKV. The following sets of specific primers for DENV-
2 (Den2-911F 5′-TGACRG CTGTCGCTCCTTCA-3′,
Den2-2444R 5′-CARCTCACAAYGCAACCACTATC-3′,
1485 bp), DENV-3 (Den3-815F 5′-GCCCTTAGGCACCC
AGGGTT-3′, Den3-1752R 5′-CCCGCGAAAATGCTTG
TGC-3′, Den3-1398F 5′-CGCAAGGAG TCACGGCT
GAG-3′, Den3-2539R 5′-GCCTGCAATGGCTGTTGC
C-3′, 1479 bp) [7], and CHIKV (Chik E1Fseq1 5′-GCT
CCGCGTCCTTTACC-3′, Chik E1RSeq1 5′-ATGGCG
ACGCCCCCAAAGTC, 540 bp) were used for the PCRamplification. The PCR amplicons were directly se-
quenced using the BigDye® Terminator v3.1 cycle sequen-
cing kit (Applied Biosystems). The sequencing was
performed using the following conditions: 96 °C for 1 min
followed by 35 cycles of 96 °C for 10 s, 50 °C for 5 s, and
60 °C for 4 min. Sequence chromatograms for both
strands were obtained using an ABI3730XL automated se-
quence analyzer (Applied Biosystems).
Phylogenetic analysis of DENV and CHIKV
The complete nucleotide sequences of the E gene of the
Laotian DENV-2 (1485 bp) and DENV-3 (1479 bp)
strains, and the partial nucleotide sequences of the E1
gene of CHIKV (540 bp) were aligned using ClustalW
[15]. A phylogenetic tree was constructed using the
maximum likelihood (ML) method. The ML analysis
was performed using the General Time Reversible
(GTR) model with a gamma distribution, and the pro-
portion of invariable sites (I) was estimated by MEGA
v5.2 (www.megasoftware.net) [16]. The reliability of the
analysis was evaluated in a bootstrap test with 10,000
replications. Representative strains of the DENV-1 and
DENV-3 serotypes were used as the outgroup taxon for
the DENV-3 and DENV-2 tree, respectively. The
Table 1 Clinical features of hospitalized patients (N = 40)




Retro-orbital pain (eye pain) 29 72.5
Digestive problems (nausea/vomiting) 17 42.5
Muscle pain (myalgia) 35 87.5
Join pain (arthralgia) 28 70
Chills 7 17.5
Skin rash 6 15
Petechiae 2 5
Bleeding nose or gum 2 5
Bleeding within 8 days 1 2.5
Clinical tests
Tourniquet test 40 100
Leukopenia (<5000/mm3) 30 78.9
Thrombocytopenia (<100,000/mm3) 13 34.2
Elevated hematocrit (>20 % increased) 9 23.1
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(GenBank accession number: NC001512 and AF192890),
was used as an outgroup for the CHIKV tree [17]. Se-
quences of all Laotian DENV and CHIKV are deposited
in the DNA Data Bank of Japan (DDBJ) under accession
number LC147056-LC147057 for DENV-2, LC147058-
LC147061 for DENV-3, and LC147062-LC147064 for
CHIKV, respectively.
Ethics statement
This study was approved (No. 276/NECHR) by the Na-
tional Ethics Committee for Health Research, Ministry
of Health, Lao PDR, and the Institutional Review Board
of Kansai Medical University (reference no.1430). In-
formed consent was obtained from each participant, as




All of the plasma samples were collected from patients
with suspected DENV infections that were treated at the
Champasak hospital during an outbreak of DF. Forty
subjects were enrolled (13 in the 5–15 years age group,
23 in the 16–45 years age group, and 4 in the 46–
65 years age group), and 22 (55 %) of them were female.
The median age of the patients was 20.50 years (range
5–65 ).
As shown in Table 1, all of the patients developed a
fever (days 1–6) and produced positive results in the
tourniquet test. Nearly all of the patients (97.5 %) experi-
enced headaches during their hospitalization. Muscle
pain was present in 87.5 % of patients, and joint pain
(70 %) and retro-orbital pain (72.5 %) were also com-
mon. Digestive problems were observed in 17 (42.5 %)
patients. The patients’ other symptoms included chills
(17.5 %), skin rash (15 %), bleeding from the nose or
gums (5 %), petechiae (5 %), and bleeding that occurred
within 8 days of onset (2.5 %). Seventy-nine percent of
the patients exhibited lower white blood cell counts
(leukopenia <5000/mm3). Thrombocytopenia (<100,000/
mm3) was observed in 34 % of cases, and 23 % of pa-
tients were presented with increases in their HCT levels
of >20 % compared with the baseline. There were no
deaths during the study period.
Screening of clinical samples by PCR
Detection and typing of the four DENV serotypes and
CHIKV in plasma samples by PCR assay using specific
primers for DENV serotypes 1 to 4 and CHIKV.
In the results of the 40 specimens, 7 (17.5 %) and 5
(12.5 %) were found to be positive for DENV-2 and
DENV-3, respectively. However, DENV-1 and DENV-4
were not detected in the present study. Furthermore,DENV-2 and DENV-3 co-infection was detected in 2
(5 %) samples. Moreover, CHIKV was also detected in
10 samples (25 %). Of the 10 CHIKV-positive cases, 3
samples were co-infected by DENV-2 and 3 samples co-
infected by DENV-3, respectively. The sequences of
these PCR products from all positive samples were also
confirmed by sequencing analysis.
DNA sequencing analysis
Serotypes/genotypes were determined by PCR and/or se-
quencing analysis using forward and reverse primers of
the complete envelope gene of DENV-2 (Den2-911F and
Den2-2444R, 1485 bp) and DENV-3 (Den3-815F and
Den3-1752R; Den3-1398F and Den3-2539R, 1479 bp),
and partial E1 gene of CHIKV (Chik E1Fseq1 and Chik
E1RSeq1, 540 bp). Entire gene sequences of two DENV-
2, four DENV-3, and partial gene sequences of three
CHIKV were then analyzed by phylogenetic analysis.
The results showed that the percentage of similar among
the two DENV-2 was 99 %, four DENV-3 ranged from
90 to 97 %, CHIKV ranged from 62 to 67 % when those
compared to each other and to strains representative of
the different serotypes/genotypes available on GenBank.
Phylogenetic analysis of DENV-2
The complete E gene sequences of two distinct DENV
isolates (LAO13VTE582 and LAOCPS13C33) from the
2013 outbreak were determined and compared with se-
quences of 37 representative DENV-2 strains of each
genotype published in GenBank. Two strains of DENV-2
from Laos viruses were closely related each other and
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Asian I consists of viruses mainly from Southeast Asia,
including Thailand, Cambodia, Vietnam, China, and
Myanmar. No Asian II genotype and Asian/America
genotype strains were found during dengue outbreak in
Laos 2013.
Phylogenetic analysis of DENV-3
The DENV-3 strains isolated in the current study and
previously isolated DENV-3 strains from other provinces
of Laos (Laungprabang, Oudomsay, and Champasak)
and Vientiane were compared with sequences of 34 rep-
resentative DENV-3 strains of each genotype obtained
from GenBank database. Sequences of four strains for
DENV-3 from Laos were grouped together within geno-
type II (Fig. 3). The genotype II of DENV-3 is common
in Southeast Asian countries and clusters within the
viral strains from China, Myanmar, the Philippines,
Bangladesh, Thailand, Cambodia, and Vietnam. The add-
itional DENV-3 isolated in Vientiane in 2013 (LAOV-
TE13LN680428 and LAOVTE13LN680428) [7] belongFig. 2 A maximum likelihood tree constructed based on the complete env
together with its country of origin followed by two digits, which indicate t
Two representative strains that were isolated in the present study are indic
scale bar indicates the mean number of nucleotide substitutions per siteto genotype III (Fig. 3). No genotype I and genotypes III
strains were found in the study period.
Phylogenetic analysis of CHIKV
Analysis of the partial E1 gene sequences of 19 represen-
tative strains of each genotype of CHIKV published in
GenBank, including sequences of three representative
strains of CHIKV from Laos demonstrated that all
CHIKV strains from the present study were closely re-
lated to each other and other viruses from Cambodia
(isolated in 2011) [18]. All study sequences clustered to-
gether with the causative CHIKV strains isolated during
an epidemic in the Indian Ocean Islands and belonged
to the East Central South African genotype (ECSA). The
ECSA genotype consists of viral strains from Southeast
Asia and other countries, including Reunion Island and
Kenya (Fig. 4).
Discussion
In 2013, Laos experienced a major DF/DHF outbreak
presented with nearly 50,000 dengue cases and 92 deathselope gene sequence of DENV-2. Each DENV-2 isolate is shown
he year in which it was isolated, and its GenBank accession number.
ated by filled triangles. Bootstrap values of <60 % are not shown. The
Fig. 3 A maximum likelihood tree constructed based on the complete envelope gene sequence of DENV-3. Each DENV-3 isolate is shown
together with its country of origin followed by two digits, which indicate the year in which it was isolated and its GenBank accession number.
Four representative strains that were isolated in the present study are indicated by filled triangles. Bootstrap values of <60 % are not shown. The
scale bar indicates the mean number of nucleotide substitutions per site
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ical features with DENV infection and co-circulates in
overlapping geographic distributions, therefore, CHIKV
may be misdiagnosed in areas where DENV endemic
occur [10]. During dengue fever outbreak, the Lao med-
ical doctor only diagnosed the dengue infections among
patients. Consequently, we want to identify that these
patients are really infected by dengue virus or other in-
fectious disease. The present study showed that fever,
headache, retro-orbital pain, a positive tourniquet test,
and body and joint pain are common symptoms in pa-
tients that have been infected with DENV. Additionally,
our data also revealed that arthralgia (joint pain) and
skin rash were the most common symptoms found in
CHIKV-infected patients (data not shown), and similar
findings were reported by Ali et al.[19].
In our study, a molecular screening specific for both
DENV and CHIKV infections was performed on 40
acute-phase plasma samples collected from patients withsuspected dengue infection in southern Laos during an
outbreak between July and August 2013. DENV was de-
tected by PCR in 30 % and CHIKV in 12.5 % of samples.
Two samples (5 %) were co-infected by both viruses
(DENV-2 and DENV-3), and five samples (12.5 %) were
co-infected by DENV and CHIKV, respectively. Although
the enrolled patients included five cases that were
suffering from DHF, none of the patients died, and
no cases of DENV-1 or DENV-4 were found during
the study period. In our analysis of 40 samples,
52.5 % were found to be dengue-negative by RT-PCR.
These samples might not have been collected during
the acute phase of the infection (plasma viremia re-
duction) [20].
In Laos, the dominance serotype changes from year to
year since 2010. DENV-1 was dominant in 2010 and
2011; DENV-3 was dominant in 2012 followed by
DENV-2, according to the National Dengue surveillance,
Lao PDR [8]. Our findings indicated that both DENV-2
Fig. 4 A maximum likelihood tree constructed based on the partial envelope (E1) gene sequence of CHIKV. Each CHIKV isolate is shown together
with its country of origin followed by two digits, which indicate the year in which it was isolated and its GenBank accession number. Three
representative strains that were isolated in the present study are indicated by filled triangles. Bootstrap values of <60 % are not shown. The scale
bar indicates the mean number of nucleotide substitutions per site
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circulating in southern Laos in 2013. In addition, other
researchers reported that DENV-3 (94 %) was dominant,
followed by DENV-2 (3 %) circulating virus in Vientiane
capital, whereas few cases of DENV-1 and DENV-4
(ranged from <1 to <6 %) have been recorded from May
2012 to December 2013 [7]. That corresponds with our
data; DENV-1 and DENV-4 were not detected. Concur-
rent infection by multiple DENV serotypes (DENV-2
and DENV-3) was identified during the 2013 dengue
outbreak in Laos. Furthermore, co-circulation of DENV-
2 (38.7 %) and DENV-3 (29.3 %) were also reported in
Thailand during dengue outbreak from 2004 to 2010
[21]. These findings suggested that DENV serotype 2
and 3 may have remained viruses in the circulation in
these areas for a long time or they may have been intro-
duced from a neighboring country such as Thailand.
Geographically, Laos is located nearby Thailand com-
pared with other countries in Southeast Asia. With the
increased movement and/or migration of infected people
within and between countries, hyperendemicity (the co-
circulation of multiple DENV serotypes) may be oc-
curred [22].
The first case of dual infection with DENV-1 and
DENV-2 was a resident in Vientiane, the capital of Laos,
who was presented with mild symptoms of dengue,which were not severe enough to require admission [6].
Since then, there have been no further reports of dual
DENV infections in Laos. According to the data ob-
tained in the present study, we also found that the co-
infected patients were more likely to present the DHF
including, fever, digestive trouble, skin rash, a positive
tourniquet test, leukopenia, and bleeding; these pa-
tients needed admission to hospital during their
illness.
We determined the genotypes of the isolated DENV-2
and DENV-3 viruses via phylogenetic analyses of their
complete E gene sequences. DENV-2 is categorized into
five genotypes: cosmopolitan, Asian-I, Asian-II, Asian-
American, and American [23].
Based on complete E gene sequences, DENV-2 has
been divided into five genotypes: Cosmopolitan, Asian-I,
Asian-II, Asian-American, and American [23]. The Lao-
tian DENV-2 were collected in the 2013 outbreak from
different localities in Laos (610 km South (Champasak
province)–Central (Vientiane capital)). Sequences of
these two viruses strains of DENV-2 were closely related
within genotype Asian I (Fig. 2). The genotype Asian I
of DENV-2 isolates from Laos in 21010 and 2013
grouped together with viruses from Southeast Asian
countries, including Cambodia (2009), Thailand (2010),
Vietnam (2010 and 2011), Myanmar (2010), China
Phommanivong et al. Tropical Medicine and Health  (2016) 44:24 Page 8 of 10(2009), Southeast Asia (2010), and Laos (2010) [24, 25].
The genotype Asian I found in the current study and
those from Southeast Asian countries formed a mono-
phyletic relationship with very high support values
greater than 98 % are shown. We suggested that the
genotype Asian I of DENV-2 has remained in dominant
circulation in Laos for a long time since 2010 until an
outbreak in 2013. The genotype Asian I of DENV-2 is
also the predominant genotype circulating in many parts
of Southeast Asia, except Malaysia, Singapore, Indonesia,
and the Philippines [23].
Among the five genotypes of DENV-3 (I–V) [26],
sequences of DENV-3 strains from the 2013 outbreak, to-
gether with other Laotian sequences collected from
Laungprabang, Oudomsay, and Champasak provinces and
Vientiane capital were grouped into the same cluster
within genotype II (Fig. 3). The Laotian DENV-3 genotype
II isolates were most closely related to those isolated from
China (2013), Myanmar (2009), Bangladesh (2008), the
Philippines (2010), Thailand (2010), Cambodia (2008), and
Vietnam (2010) [25, 27]. All of the Laotian DENV-3 geno-
type II viruses obtained in this study and sequences from
other Southeast Asian countries formed a monophyletic
relationship with very high values bootstrap support
(>98 %). We suggested that they had a single origin and
have been circulating in Lao PDR for a long time. Two
different genotypes of DENV-3 (genotype II and III) have
been reported to have co-circulated in Laos in 2013 [7].
Even though two studies have been implemented in the
same year, the findings are not the same. Although our
sample size is small, the analysis presented in this study
suggested that DENV-3 genotype II is circulating in the
southern parts of Laos and has also invaded other parts of
the country. Moreover, DENV-3 genotype II is the domin-
ant circulating genotype in many countries in Southeast
Asia [25].
Despite the small number of reported cases at the
National dengue surveillance in the Lao PDR, and the
fact that our study could only identify that two (5 %)
cases of concurrent co-infection of DENV serotypes 2
and 3 were observed, Lardo et al. reported that concur-
rent infections of dengue viruses 2 and 3 have been pro-
posed as one of contributing factors to severe dengue
[28]. In the present study, it is difficult to conclude that
a co-infected patient with two serotypes (i.e., DENV-2
and DENV-3) became afflicted with a more severe form
of dengue (DHF/DSS) because of only two cases were
experienced. Moreover, we did not have enough infor-
mation about their clinical symptoms during hospital
admission. In addition, the relationship between concur-
rent infections and severe forms of dengue (DHF/DSS)
requires further study.
On the other hand, the current chikungunya epidemic
in Southeast Asia is being driven by the appearance of astrain of CHIKV that originated in Africa [29] and
spread to Asian countries such as Cambodia [18] and
Thailand [30]. At present, CHIKV is known to be circu-
lating in southern Laos [11] and is currently spreading
to other regions of the country. During the 2013 out-
break of DENV in Laos examined in this study, we also
found patients that had been infected with CHIKV. In
fact, CHIKV-positive patients accounted for 25 % (10/
40) of patients and 12.5 % (5/40) of the patients were
co-infected with DENV-2 or DENV-3. Other studies
have already recorded a high proportion of double in-
fected cases with CHIKV and DENV (29 % from New
Delhi, India, 12.4 % from West Bengal, India, and 37
cases from Gabon) [31, 32]. Detection of double infec-
tion of CHIKV and DENV in this study demonstrated
the probability that many chikungunya cases may go
misdiagnosed in areas where two viruses coexist [10]. In
Laos, a diagnosis of dengue and chikungunya infection
was based on patient’s clinical symptoms and in general
samples were not checked by serological test such as a
rapid test. In this study, we did not perform the virus
isolation from samples.
Phylogenetic analysis divided CHIKV isolates into
three distinct genotypes based on their geographic ori-
gins: the West African (WAf) genotype, East/Central/
South African (ECSA) genotype, and Asian genotype
[33]. Our findings demonstrated that the partial E1 gene
sequences of the Laotian CHIKV strains clustered to-
gether with homologous strains from Indian Ocean
CHIKV outbreaks within the ECSA genotype. All of
these Laotian CHIKV strains were closely related to the
CHIIKV strains that caused outbreaks in Cambodia, but
not high bootstrap support values below 70 (Fig. 4) [18]
and clustered together with other isolates from recent
outbreaks in Asian countries (Thailand, Myanmar,
China, Cambodia, Malaysia, Sri Lanka, and India) [18,
30, 34]. A high degree of sequence similarity between
the Laotian and Cambodian strains and the fact that the
Cambodian CHIKV outbreak occurred in 2011 where
sharing borders with southern Laos and data from com-
munity survey [11], we suggested that CHIKV ECSA
genotype is still endemic or is continuously reintroduced
to the area and has invaded various regions of Laos.
Conclusions
Dengue is still a prevalent mosquito-borne disease in
Laos. Molecular detection and serotyping of dengue and
chikungunya were carried out on acute-phase plasma
samples that were collected during the 2013 dengue
fever outbreak from Laos. Our data suggested that the
identification of concurrent infection with two serotypes
(DENV-2 and DENV-3) and co-infections with CHIKV
and two DENV serotypes have been confirmed during
the 2013 outbreak. Furthermore, our study indicated
Phommanivong et al. Tropical Medicine and Health  (2016) 44:24 Page 9 of 10that the occurrence of DENV and CHIKV co-infections
occurred in areas where these two viruses co-circulated.
This is the first study to report on patients that had been
co-infected with CHIKV and one of two DENV serotypes
in Laos. These findings from our study will be helpful in
the mitigation of priority actions such as improving sur-
veillance and timely intervention to present and future
outbreak threats.
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